Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.

Matsuo K, Yokota Y, Zhai Y, Quan YS, Kamiyama F, Mukai Y, Okada N, Nakagawa S.

J Control Release. 2012 Jul 10;161(1):10-7. doi: 10.1016/j.jconrel.2012.01.033. Epub 2012 Jan 28. Erratum in: J Control Release. 2014 Jun 28;184:9.

PMID:
22306332
2.

Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.

Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, Suzuki H, Katayama I, Okada N, Nakagawa S.

Pharm Res. 2013 Oct;30(10):2664-74. doi: 10.1007/s11095-013-1092-6. Epub 2013 Jun 18.

PMID:
23775442
3.

Parameter optimization toward optimal microneedle-based dermal vaccination.

van der Maaden K, Varypataki EM, Yu H, Romeijn S, Jiskoot W, Bouwstra J.

Eur J Pharm Sci. 2014 Nov 20;64:18-25. doi: 10.1016/j.ejps.2014.08.004. Epub 2014 Aug 20.

PMID:
25151530
4.

Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.

Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y.

Int J Pharm. 2013 Apr 15;447(1-2):22-30. doi: 10.1016/j.ijpharm.2013.02.006. Epub 2013 Feb 11.

PMID:
23410987
5.

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

Matsuo K, Okamoto H, Kawai Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S.

J Neuroimmunol. 2014 Jan 15;266(1-2):1-11. doi: 10.1016/j.jneuroim.2013.11.002. Epub 2013 Nov 11.

PMID:
24315156
6.

Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.

Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan YS, Kamiyama F, Tougan T, Horii T, Mukai Y, Okada N, Nakagawa S.

J Control Release. 2012 Jun 28;160(3):495-501. doi: 10.1016/j.jconrel.2012.04.001. Epub 2012 Apr 11. Erratum in: J Control Release. 2014 Jun 28;184:18-9.

PMID:
22516091
7.

Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Matsuo K, Hirobe S, Okada N, Nakagawa S.

Vaccine. 2013 May 1;31(19):2403-15. doi: 10.1016/j.vaccine.2013.03.022. Epub 2013 Mar 21. Review.

PMID:
23523401
8.

Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.

Matsuo K, Ishii Y, Quan YS, Kamiyama F, Asada H, Mukai Y, Okada N, Nakagawa S.

Biol Pharm Bull. 2011;34(12):1835-40.

9.

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.

Hirobe S, Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S.

Biomaterials. 2015 Jul;57:50-8. doi: 10.1016/j.biomaterials.2015.04.007. Epub 2015 Apr 24.

PMID:
25913250
10.

Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

McCrudden MT, Torrisi BM, Al-Zahrani S, McCrudden CM, Zaric M, Scott CJ, Kissenpfennig A, McCarthy HO, Donnelly RF.

J Pharm Pharmacol. 2015 Mar;67(3):409-25. doi: 10.1111/jphp.12248. Epub 2014 Mar 27.

PMID:
24673568
11.

Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.

van der Maaden K, Varypataki EM, Romeijn S, Ossendorp F, Jiskoot W, Bouwstra J.

Eur J Pharm Biopharm. 2014 Oct;88(2):310-5. doi: 10.1016/j.ejpb.2014.05.003. Epub 2014 May 9.

PMID:
24820032
12.

Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.

Katsumi H, Liu S, Tanaka Y, Hitomi K, Hayashi R, Hirai Y, Kusamori K, Quan YS, Kamiyama F, Sakane T, Yamamoto A.

J Pharm Sci. 2012 Sep;101(9):3230-8. doi: 10.1002/jps.23136. Epub 2012 Mar 29.

PMID:
22467424
13.

Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.

Kumar A, Li X, Sandoval MA, Rodriguez BL, Sloat BR, Cui Z.

Int J Nanomedicine. 2011;6:1253-64. doi: 10.2147/IJN.S20413. Epub 2011 Jun 21.

14.

Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.

Liu S, Jin MN, Quan YS, Kamiyama F, Kusamori K, Katsumi H, Sakane T, Yamamoto A.

Eur J Pharm Biopharm. 2014 Feb;86(2):267-76. doi: 10.1016/j.ejpb.2013.10.001. Epub 2013 Oct 9.

PMID:
24120887
15.

Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.

Naito S, Ito Y, Kiyohara T, Kataoka M, Ochiai M, Takada K.

Vaccine. 2012 Feb 1;30(6):1191-7. doi: 10.1016/j.vaccine.2011.11.111. Epub 2011 Dec 13.

PMID:
22172508
16.

Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.

Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, Cormier M.

Vaccine. 2006 Mar 6;24(10):1653-64. Epub 2005 Oct 6.

PMID:
16246466
17.

Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.

Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, Kersten G, Bouwstra JA.

J Control Release. 2009 May 21;136(1):71-8. doi: 10.1016/j.jconrel.2009.01.025. Epub 2009 Feb 6.

PMID:
19331846
18.

Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.

Guo L, Qiu Y, Chen J, Zhang S, Xu B, Gao Y.

Biomed Microdevices. 2013 Dec;15(6):1077-85. doi: 10.1007/s10544-013-9799-z.

PMID:
23893014
19.

Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice.

Carey JB, Pearson FE, Vrdoljak A, McGrath MG, Crean AM, Walsh PT, Doody T, O'Mahony C, Hill AV, Moore AC.

PLoS One. 2011;6(7):e22442. doi: 10.1371/journal.pone.0022442. Epub 2011 Jul 25.

20.

Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat.

Matsuo K, Ishii Y, Quan YS, Kamiyama F, Mukai Y, Yoshioka Y, Okada N, Nakagawa S.

J Control Release. 2011 Jan 5;149(1):15-20. doi: 10.1016/j.jconrel.2010.05.012. Epub 2010 May 19.

PMID:
20493218

Supplemental Content

Support Center